Briefing

Featured article

Novo Nordisk’s CEO to step down as weight loss market share plummets

Also in this section

News in Numbers

Latest News

Latest Deals

05/23/2025 08:35:56
  • Home | Are regulators keeping pace with AI adoption in clinical trials?
  • Editor's letter
  • Contents
  • Mimotopes Company Insight
  • Mimotopes
  • Cartherics Company Insight
  • Briefing
  • News in Numbers
  • Latest News
  • Latest Deals
  • Datwyler Company Insight
  • Datwyler
  • Nipro
  • In Depth
  • Are regulators keeping pace with AI adoption in clinical trials?
  • Power of collaboration more pertinent than ever says pharma experts
  • Newborn screening strategy needs modernising as HHS disbands advisory committee
  • Pharma’s AI prospects get nudged into the future with EU’s AI act
  • ATS 2025: Anti–IL-5 therapy cuts exacerbations in coexisting COPD and asthma patients
  • ATS 2025: Real-world data supports Trikafta as gold standard in long-term CF care
  • B Medical Systems Company Insight
  • Endress+Hauser
  • SCHOTT Pharma Company Insight
  • Listings
  • Events
  • Excellence Awards
  • Buyer's Guides
  • Next issue
05/23/2025 00:00:00